SCHEMBL6764780

SCHEMBL6764780

CC(Oc1ccc(Cl)cc1Cl)C(=O)NN

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.70
ALDH1A1 P00352 3/20 0.65
KDM4E B2RXH2 2/20 0.65
GAA P10253 2/20 0.65
LMNA P02545 5/20 0.64
HPGD P15428 4/20 0.64
TSHR P16473 1/20 0.64
MAPK1 P28482 1/20 0.64
OGG1 O15527 1/20 0.62
PKM P14618 1/20 0.61
L3MBTL1 Q9Y468 3/20 0.60
HTT P42858 2/20 0.60
MEN1 O00255 2/20 0.56
MAPT P10636 2/20 0.56
KMT2A Q03164 2/20 0.56
CYP1A2 P05177 1/20 0.56
GLA P06280 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4164467 0.83 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1KDM4EGAALMNA
SCHEMBL21056089 0.83 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1KDM4EGAALMNA
SCHEMBL10175710 0.82 ALDH1A1 (0.87) SMN1; SMN2ALDH1A1KDM4EGAALMNA
SCHEMBL10445559 0.81 SMN1; SMN2 (0.65) SMN1; SMN2ALDH1A1KDM4EGAALMNA
Rac-Dichlorprop SCHEMBL28260779 0.81 TSHR (0.69) SMN1; SMN2ALDH1A1KDM4EGAALMNA
SCHEMBL29996006 0.81 SMN1; SMN2 (0.65) SMN1; SMN2ALDH1A1KDM4EGAALMNA
SCHEMBL29106733 0.81 SMN1; SMN2 (0.65) SMN1; SMN2ALDH1A1KDM4EGAALMNA
Rac-Dichlorprop SCHEMBL54510 0.81 TSHR (0.73) SMN1; SMN2ALDH1A1KDM4EGAALMNA
(S)-Dichlorprop SCHEMBL1535831 0.81 TSHR (0.73) SMN1; SMN2ALDH1A1KDM4EGAALMNA
SCHEMBL6704326 0.81 SMN1; SMN2 (0.64) SMN1; SMN2ALDH1A1KDM4EGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6730704-B2 REACTING AN ARYLOXYPROPIONIC ACID HYDRAZIDE WITH AN ARYLSULFONYL CHLORIDE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2004-05-04 US disclosed
US-20030187065-A1 1-(ARYLOXY)PROPIONOYL-2-ARYLSULFONYL HYDRAZINES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS HYPOGLYCEMIC AGENTS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 2003-10-02 US disclosed
US-3972905-A FUNGICIDE BAYER AKTIENGESELLSCHAFT (DT) 1976-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187065-A1 1-(ARYLOXY)PROPIONOYL-2-ARYLSULFONYL HYDRAZINES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS HYPOGLYCEMIC AGENTS IAPP, DPP4, GLP1R SMN1; SMN2 4320/4885ALDH1A1 292/4885KDM4E 786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.